Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports

  • 📰 SaltWire Network
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 63%

مصر أخبار أخبار

Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
مصر أحدث الأخبار,مصر عناوين

Explore stories from Atlantic Canada.

Seniors displaced after Yarmouth fire | SaltWire #fire #yarmouth #seniors #news -Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the Wall Street Journal reported on Tuesday.

Eyebiotech is a clinical stage opthalmology company, with operations in the U.S. and the UK, that seeks to treat patients with sight-threatening diseases.

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

SaltWire Network /  🏆 45. in EG
 

مصر أحدث الأخبار, مصر عناوين